Merck
AI-Driven Retrosynthesis
The development of cost-effective and safe total synthetic routes for active pharmaceutical ingredients (APIs) is a painstaking and complex process. This critical early development stage significantly impacts overall manufacturing costs, dictates the required purification and isolation technologies along with inherent solvent usage, and consequently contributes to key environmental hotspots in pharmaceutical manufacturing.
Prof. Brahim Benyahia
Professor of Chemical Engineering, Loughborough University
Dr. Ewa Gajewska
Head of Product Management
Register for webinar
Prof. Brahim Benyahia, Dr. Ewa Gajewska
AI-Driven Retrosynthesis
Topics
Webinars on related topics
Products on related topics
White papers on related topics
More webinars from Merck
More webinars on similar topics
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
